Navigation Links
Huifeng Bio-Pharmaceutical (HFGB) Announces 2007 Full Year Results
Date:3/31/2008

XI'AN, China, March 31 /Xinhua-PRNewswire-FirstCall/ -- Huifeng Bio- Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB), a developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production, is pleased to announce its audited financial results for the year ended December 31, 2007.

Full Year 2007 Highlights:

The following is a summary of our financial results for the full year ended Dec. 31, 2007.

12 Months Ended 12 Months Ended Growth

In US Dollars December 31,2007 December 31,2006 %

Net Revenue $6,571,531 $3,076,779 114%

Gross Profit $1,977,313 $457,518 332%

Gross Profit Margin 30% 15%

Net Income $1,283,683 $131,736 874%

Net Income Margin 20% 4%

Earnings Per Share $0.07 $0.01 600%

Huifeng achieved outstanding growth during 2007, with sales more than doubling and net income increasing by over 800%. "Huifeng achieved a number of significant milestones in 2007. We have increased our product offering and achieved significant sales in both Rutin and Diosmin," states company CEO Jing'An Wang. Furthermore, in late 2007, Huifeng signed the largest supply agreement in company history and completed a $2 million fundraising.

"Huifeng expects to continue achieving significant gains in both sales and net income in 2008 through organic growth of our current products," forecasted Mr. Wang. The company restructured its production lines in the fourth quarter to accommodate the increased production levels of Diosmin necessitated under its current contract with Safic-Alcan of France. Huifeng also hopes to close a strategic acquisition in 2008 under its sta
'/>"/>

SOURCE Huifeng Bio-Pharmaceutical Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
2. Skystar Bio-Pharmaceutical Raises 2007 Revenue Guidance to $15.8 Million
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
5. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
6. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
7. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
8. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Nasseo, Inc. today announces that it has been ... of applicants by the Arizona Commerce Authority (ACA) ... The Arizona Innovation Challenge (AIC) awards the most money ... a financial award to what it deems to be ... the art dental and orthopedic implant surface modification technology ...
(Date:6/18/2013)... June 18, 2013 ... research firm, announces the initiation of full ... biopharmaceutical company developing and marketing products for ...      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) ... examining the investment merits of BioAlliance Pharma, ...
(Date:6/18/2013)... MINNEAPOLIS , June 18, 2013  Techne ... today that it has agreed to acquire 100% ... subsidiary Bionostics, Inc. (Bionostics).  Bionostics is a global ... control solutions that verify the proper operation of ... utilized in point of care blood glucose and ...
(Date:6/18/2013)... THE WOODLANDS, Texas , June 18, 2013 ... LXRX ), a biopharmaceutical company focused on ... that John Northcott has joined the ... strategy, and operations. Mr. Northcott brings extensive commercial ... on-market commercialization across a variety of therapeutic areas. ...
Breaking Biology Technology:Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Techne Corporation Announces Acquisition Agreement 2Techne Corporation Announces Acquisition Agreement 3Techne Corporation Announces Acquisition Agreement 4Techne Corporation Announces Acquisition Agreement 5John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 3
... subsidiary obtains $74 million term loanST. LOUIS, May 6 2009 First Quarter ... Net sales decreased to $339 million from $517 million in the first ... EBITDA decreased to $56 million from $95 million in the first quarter of 2008 ... report improved Adjusted EBITDA margins , ...
... First Quarter Financial Results Conference Call and Webcast -CHICAGO, ... today that its common stock is eligible for quotation ... the trading symbol "ADLS." The Company also announced today ... discussing the Company,s 2009 first quarter results on Tuesday, ...
... Technology experts from over 20 countries are in ... environment, topics of global importance and immediacy. The ... forum to discuss initiatives in micromachining and nano ... economic and social outcomes. , The Summit promotes ...
Cached Biology Technology:Solutia Reports First Quarter 2009 Results 2Solutia Reports First Quarter 2009 Results 3Solutia Reports First Quarter 2009 Results 4Solutia Reports First Quarter 2009 Results 5Solutia Reports First Quarter 2009 Results 6Solutia Reports First Quarter 2009 Results 7Solutia Reports First Quarter 2009 Results 8Solutia Reports First Quarter 2009 Results 9Solutia Reports First Quarter 2009 Results 10Solutia Reports First Quarter 2009 Results 11Solutia Reports First Quarter 2009 Results 12Solutia Reports First Quarter 2009 Results 13Solutia Reports First Quarter 2009 Results 14Solutia Reports First Quarter 2009 Results 15Solutia Reports First Quarter 2009 Results 16Solutia Reports First Quarter 2009 Results 17Solutia Reports First Quarter 2009 Results 18Solutia Reports First Quarter 2009 Results 19Solutia Reports First Quarter 2009 Results 20Solutia Reports First Quarter 2009 Results 21Advanced Life Sciences Common Stock Begins Trading on OTC Bulletin Board 2World Micromachine Summit highlights technologies impacting energy and the environment 2
(Date:6/17/2013)... fungi, bacteria, and algae, is a common component of ... in the medical field it,s approved by the ... and used during surgery as a substance that opens ... drugs. , Now Profs. Ehud Gazit and Daniel Segal ... Biotechnology and the Sagol School of Neuroscience, along with ...
(Date:6/17/2013)... 2013) The AGA Research Foundation and Horizon Pharma ... of gastroenterology with the 2013 AGA-Horizon Pharma Fellow Abstract ... , "In its third year, this competition continues to ... on promising careers in basic and clinical research," said ... Research Foundation. "We are extremely proud of all that ...
(Date:6/17/2013)... CORVALLIS, Ore. Amphibian populations are declining worldwide and ... be spread by bullfrogs, but a two-year study shows ... suggestions that bullfrogs are a tolerant carrier host that ... frogs from eggs in controlled experimental conditions, they found ... dendrobatidis , also called Bd or a chytrid fungus, ...
Breaking Biology News(10 mins):Artificial sweetener a potential treatment for Parkinson's disease 2Horizon Pharma Abstract Prizes recognize promising fellows and students 2Bullfrogs may help spread deadly amphibian fungus, but also die from it 2
... Duchenne muscular dystrophy (DMD) tend to manage well through ... early adulthood, or why elderly people who lose muscle ... to regain. Now, researchers at the National Institute of ... the National Institutes of Health, are beginning to find ...
... Palo Alto, CABrazilians are world leaders in using biofuels ... consumption comes from sugarcane, which significantly reduces carbon dioxide ... Now scientists from the Carnegie Institution,s Department of Global ... Expansion of the crop in areas previously occupied by ...
... Michael Croft, Ph.D., a researcher at the La ... molecule,s previously unknown role as a major trigger for ... a promising therapeutic target for chronic asthma, chronic obstructive ... A scientific paper on Dr. Croft,s finding was published ...
Cached Biology News:NIH scientists identify gene that could hold the key to muscle repair 2Sugarcane cools climate 2La Jolla Institute identifies new therapeutic target for asthma, COPD and other lung disorders 2La Jolla Institute identifies new therapeutic target for asthma, COPD and other lung disorders 3
Glucagon-like peptide-1 (GLP-1 (1-36) amide)...
... Molecule Localization in Early Drug Development with ... Get essential drug compound localization data in ... Discoverys imaging mass spectrometry service maps ... histological images so you can localize drugs ...
Best pricing for 100mg-1.0g scales. Phosphopeptides are our specialty....
... The ProteomeLab PF 2D is an ... of complex protein mixtures. Part of ... PF 2D produces results in just hours. ... of proteins present in cell lysates, addressing ...
Biology Products: